Transfected human amniotic cells and method for producing a gene product
First Claim
Patent Images
1. An in vitro method for transfecting human amniotic cells comprising, transfecting said human amniotic cells with a recombinant adenovirus encoding a desired gene, wherein the gene is expressed by said human amniotic cells.
1 Assignment
0 Petitions
Accused Products
Abstract
The present invention provides a human amniotic cell in which a gene desired to be expressed is introduced, and wherein said human amniotic cell expresses the product encoded by said gene. The present invention also provides a method for treating hereditary diseases comprising transplanting the human amniotic cells.
-
Citations
2 Claims
- 1. An in vitro method for transfecting human amniotic cells comprising, transfecting said human amniotic cells with a recombinant adenovirus encoding a desired gene, wherein the gene is expressed by said human amniotic cells.
Specification
-
- Resources
Litigation Campaign Assessment
Thank you for your request. You will receive a custom alert email when the Litigation Campaign Assessment is available.
×
-
Current AssigneeSRL Incorporated (H.U. Group Holdings, Inc.)
-
Original AssigneeSRL Incorporated (H.U. Group Holdings, Inc.)
-
InventorsSakuragawa, Norio
-
Primary Examiner(s)Hauda, Karen M.
-
Application NumberUS08/641,214Time in Patent Office1,596 DaysField of Search435/320.1, 435/240.2, 435/6, 435/69.1, 435/172.3, 435/366, 435/375, 424/93.21, 935/62, 935/52, 935/32, 935/71, 935/65US Class Current435/366CPC Class CodesC12N 15/86 Viral vectorsC12N 2710/10343 viral genome or elements th...
